Invenomic Capital Management LP Dentsply Sirona Inc. Transaction History
Invenomic Capital Management LP
- $2.05 Billion
- Q4 2024
A detailed history of Invenomic Capital Management LP transactions in Dentsply Sirona Inc. stock. As of the latest transaction made, Invenomic Capital Management LP holds 2,639,161 shares of XRAY stock, worth $48.3 Million. This represents 2.44% of its overall portfolio holdings.
Number of Shares
2,639,161
Previous 876,733
201.02%
Holding current value
$48.3 Million
Previous $23.7 Million
111.22%
% of portfolio
2.44%
Previous 1.35%
Shares
2 transactions
Others Institutions Holding XRAY
# of Institutions
399Shares Held
199MCall Options Held
875KPut Options Held
560K-
Vanguard Group Inc Valley Forge, PA20.2MShares$370 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.7MShares$343 Million0.01% of portfolio
-
First Eagle Investment Management, LLC14.5MShares$266 Million0.62% of portfolio
-
Nuance Investments, LLC Kansas City, MO13.5MShares$248 Million11.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.5MShares$230 Million0.03% of portfolio
About DENTSPLY SIRONA Inc.
- Ticker XRAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 215,452,000
- Market Cap $3.95B
- Description
- DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental...